These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Is lung function really a good parameter in evaluating the long-term effects of inhaled corticosteroids in COPD? Vestbo J; Lange P Eur Respir J; 2000 Aug; 16(2):372-3. PubMed ID: 10968517 [No Abstract] [Full Text] [Related]
15. [Should we use steroids in the treatment of chronic obstructive pulmonary diseases?]. Levi Y; Maran R Harefuah; 1992 Dec; 123(11):487-9. PubMed ID: 1487210 [No Abstract] [Full Text] [Related]
16. COPD: management of acute exacerbations and chronic stable disease. Hunter MH; King DE Am Fam Physician; 2001 Aug; 64(4):603-12. PubMed ID: 11529259 [TBL] [Abstract][Full Text] [Related]
17. [Inflammatory mediators in the pathogenesis of obstructive bronchial diseases: consequences for therapy]. Hahn HL Verh Dtsch Ges Inn Med; 1988; 94():364-75. PubMed ID: 2905102 [No Abstract] [Full Text] [Related]
18. Pulmonary mucormycosis in a patient with COPD. Klemptner A Am Fam Physician; 1999 May; 59(9):2428, 2430. PubMed ID: 10323352 [No Abstract] [Full Text] [Related]
19. Inhaled steroids for chronic obstructive pulmonary disease--where are we now? Taylor DR; Wong CS N Z Med J; 2000 Aug; 113(1115):337-8. PubMed ID: 11008612 [No Abstract] [Full Text] [Related]
20. [Current problems of corticosteroid therapy in chronic obstructive respiratory tract diseases]. Meister W Z Arztl Fortbild (Jena); 1988; 82(15):711-3. PubMed ID: 3140503 [No Abstract] [Full Text] [Related] [Next] [New Search]